Kailera Therapeutics, Inc.
KLRA
$14.70
-$0.15-0.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 916.74M | 519.17M | -- | ||
| Total Receivables | 6.11M | 3.21M | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 5.92M | 7.57M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 395.00K | 360.00K | -- | ||
| Total Current Assets | 929.17M | 530.32M | -- | ||
|
|
|||||
| Total Current Assets | 929.17M | 530.32M | -- | ||
| Net Property, Plant & Equipment | 11.65M | 12.02M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 15.52M | 19.67M | -- | ||
| Total Assets | 1.21B | 624.76M | -- | ||
|
|
|||||
| Total Accounts Payable | 19.20M | 7.10M | -- | ||
| Total Accrued Expenses | 62.68M | 45.99M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 1.05M | 1.03M | -- | ||
| Total Finance Division Other Current Liabilities | 721.00K | 722.00K | -- | ||
| Total Other Current Liabilities | 721.00K | 722.00K | -- | ||
| Total Current Liabilities | 83.65M | 54.84M | -- | ||
|
|
|||||
| Total Current Liabilities | 83.65M | 54.84M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 9.17M | 9.44M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 135.00K | 201.00K | -- | ||
| Total Liabilities | 92.95M | 64.48M | -- | ||
|
|
|||||
| Common Stock & APIC | 1.68B | 15.98M | -- | ||
| Retained Earnings | -558.84M | -447.53M | -- | ||
| Treasury Stock & Other | -1.79M | -532.00K | -- | ||
| Total Common Equity | 1.12B | -432.09M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 992.36M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 992.36M | -- | ||
|
|
|||||
| Total Common Equity | 1.12B | -432.09M | -- | ||
| Total Preferred Equity | -- | 992.36M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 1.12B | 560.28M | -- | ||
|
|
|||||